These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 23609385

  • 1. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD, Luo L, Shults J.
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [Abstract] [Full Text] [Related]

  • 2. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD, Wang CH, Shwarz M, Shults J.
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 4. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD, Shults J.
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.
    Amsterdam JD, Shults J.
    J Clin Psychopharmacol; 2010 Jun; 30(3):306-11. PubMed ID: 20473068
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Amsterdam JD, Shults J.
    Am J Psychiatry; 2010 Jul; 167(7):792-800. PubMed ID: 20360317
    [Abstract] [Full Text] [Related]

  • 7. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
    Amsterdam JD, Shults J.
    Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder.
    Amsterdam JD, Luo L, Shults J.
    Br J Psychiatry; 2013 Apr; 202(4):301-6. PubMed ID: 23099447
    [Abstract] [Full Text] [Related]

  • 9. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 10. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
    Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ.
    J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402
    [Abstract] [Full Text] [Related]

  • 11. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk.
    Lorenzo-Luaces L, Amsterdam JD, Soeller I, DeRubeis RJ.
    Acta Psychiatr Scand; 2016 Jun 01; 133(6):459-69. PubMed ID: 26803764
    [Abstract] [Full Text] [Related]

  • 12. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.
    Eur Neuropsychopharmacol; 2008 Jul 01; 18(7):535-49. PubMed ID: 18501566
    [Abstract] [Full Text] [Related]

  • 13. Frequency of bipolar spectrum in 111 private practice depression outpatients.
    Benazzi F.
    Eur Arch Psychiatry Clin Neurosci; 2003 Aug 01; 253(4):203-8. PubMed ID: 12910352
    [Abstract] [Full Text] [Related]

  • 14. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.
    J Clin Psychiatry; 2010 Aug 01; 71(8):1000-6. PubMed ID: 20361912
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb 01; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 16. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.
    Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE, McElroy SL, Grunze H, Post RM.
    Bipolar Disord; 2007 Aug 01; 9(5):531-5. PubMed ID: 17680925
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct 01; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 18. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE.
    J Affect Disord; 2010 Jul 01; 124(1-2):157-63. PubMed ID: 19963274
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
    Goldberg JF, Kelley ME, Rosenquist KJ, Hsu DJ, Filkowski MM, Nassir Ghaemi S.
    J Affect Disord; 2008 Jan 01; 105(1-3):305-10. PubMed ID: 17550787
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode.
    Amsterdam JD, Garcia-España F, Fawcett J, Quitkin FM, Reimherr FW, Rosenbaum JF, Schweizer E, Beasley C.
    J Clin Psychopharmacol; 1998 Dec 01; 18(6):435-40. PubMed ID: 9864074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.